Promoting Excellence in Diabetes Care

BPDC 2022
SPEAKERS & PROGRAM

MEET OUR BPDC 2022 SPEAKERS

Justine Cain
Justine Cain

Time: 9:40 – 10:00
Topic:  Towards a world free of diabetes – the future of diabetes in Australia

Deanne Minniecon

Time: 10:00 – 10:20
Topic:  Diabetes in indigenous communities, where are we at, where do we need to be & how do we get there

Tina Thomposon
Dr Mervyn Kyi

Time: 10:50 – 11:05
Topic: A tool for the hospital, the Country or both?

Dr Peter Donovan

Time: 11:05 – 11:20
Topic: Lessons from the Queensland Inpatient Diabetes Survey (QuiDS)

Dr Sue Mei Lau

Time: 11:20 – 11:35
Topic: Implementation of a Proactive, Virtual Glucose Management Service: the Prince of Wales Diabetes Dashboard Experience

Ella Zomer

Time: 1:20 – 1:35
Topic: Existing databases and registries for type 2 – what do we have nationally and internationally

image (27)
Prof Maria Craig

Time: 1:35 – 1:50
Topic:  ADDN update – what have we already learned? Where to now?

Joel-Lasschuit
Dr Joel Lasschuit

Time: 1:50 – 2:05
Topic:   Diabetes & foot ulceration – what the data tells us, what it doesn’t, and what do we do with it all

Prof Jonathan Shaw

Time: 2:05 – 2:20
Topic:  Connecting the dots in data in diabetes databases – what do we need to do

Prof Anthony Russell

Time: 3:20 – 3:40
Topic: Has COVID-19 changed the model of diabetes care?

Kaye Farrell photo
Dr Kaye Farrell

Time: 3:40 – 4:00
Topic:   Models of Transition Care – are we delivering?

Dr Rahul Barmanray

Time: 4:20 – 4:30
Topic: Diabetes Digital Phenotyping to Improve Documentation of Diabetes in Hospital Inpatients

LM photo crop
Lucia Marhava

Time: 4:30-4:40
Topic:  Crossing the road: Improving service delivery for young adults living with diabetes transitioning into adult healthcare

Catherine Finneran
Catherine Finneran

Time: 4:40-4:50
Topic:   Development of Inpatient and Outpatient Metabolic Services and a Model of Care

DavidONeal
Professor David O'Neal

Time: 15:25-15:50
Topic: Increasing Time in Range in adult populations

Dr Lori Laffel

Time: 15:50-16:15
Topic: Increasing Time in Range in paediatric populations

Add Your Heading Text Here

BPDC 2022 PROGRAM

Add Your Heading Text Here

Click here to download the program.

Add Your Heading Text Here

Add Your Heading Text Here

JUSTINE CAIN

Towards a world free of diabetes - the future of diabetes in Australia

Biography

Ms Cain joined Diabetes Australia as the Group CEO in November 2021. Ms Cain has more than two decades of senior executive experience within the health and human services sectors. Ms Cain’s experience includes executive management roles in Operations and Strategy for one of Australia’s largest health insurers, Director of Integration with a national assistive technology company within the Aged Care and Disability Sectors, as well as significant experience leading large scale national health services.

Ms Cain has had a distinguished career leading complex organisations, including key business units of Medibank, as well as experience on the Board of Uniting Care Queensland and the Queensland Advisory Board for the Starlight Children’s Foundation.

Ms Cain’s major achievements with Medibank included winning and running the national $1.3 billion Garrison Health Services contract which provided the full range of health services for the Australian Defence Forces in Australia. Under her leadership the tender grew to $2 billion over the life of the contract.

Ms Cain has led teams of more than 2500 staff, with annual revenue of more than $580 million. Leadership has spanned management of the Beyond Blue Counselling lines, National Disability Medical Assessments, National Nurse on Call and GP After Hours services, 1800 RESPECT Domestic Violence and Sexual Assault support lines and a range of mobile health and rehabilitation services delivered in homes

SESSION DESCRIPTION

Diabetes Australia Group CEO Justine Cain will outline what Australia needs to do to meet the challenges of the diabetes epidemic

DR MERVYN KYI

A tool for the hospital, the Country or both?

Biography

Dr Mervyn Kyi is an endocrinologist and general physician at the Royal Melbourne Hospital, clinical lead of inpatient diabetes service at the Northern Hospital, and honorary fellow at the University of Melbourne, in Victoria Australia. He completed PhD studies on early intervention models of diabetes care in hospital at the Royal Melbourne Hospital.

Following his PhD, he implemented and now leads proactive inpatient diabetes service at Northern Health. As a clinician researcher, his ongoing research is focussed on therapeutics and acute care in diabetes and endocrinology in hospital.

SESSION DESCRIPTION

TBA

PETER DONOVAN

Lessons from the QuIDS

Biography

Dr Peter Donovan is an endocrinologist, general physician and clinical pharmacologist from the Royal Brisbane and Women’s Hospital and is a senior lecturer in the University of Queensland Faculty of Medicine. He has interests in the safe and quality use of medications, particularly related to insulin and other diabetes medicines and was on the Australian Commission on Safety and Quality in Health Care advisory group that developed the National subcutaneous Insulin Prescribing Chart.

Dr Donovan is a member of the Queensland Statewide Diabetes Clinical Network Steering Committee and has chaired its Inpatient Diabetes Management Working Group since 2018. In that role, Dr Donovan has been the clinical lead of the Queensland Inpatient Diabetes Survey.

SESSION DESCRIPTION

The session will provide some of the results of the Queensland Inpatient Diabetes Survey, specially related to some of the lessons learnt from undertaking the survey. The proposed title will be fine.

SUE MEI

Implementation of a Proactive, Virtual Glucose Management Service: the Prince of Wales Diabetes Dashboard Experience

Biography

Sue Mei is a Senior Staff Specialist and Head of the Department of Diabetes and Endocrinology at the Prince of Wales Hospital, Sydney.

SESSION DESCRIPTION

This presentation outlines our experience and pilot outcomes of the first three months of implementation of the Diabetes Dashboard.

DR JOEL LASSCHUIT

Diabetes & foot ulceration - what the data tells us, what it doesn't, and what do we do with it all

Biography

Dr Joel Lasschuit (BMedSc, MBBS Hons, FRACP) is an Endocrinologist and clinical researcher who is determined to improve outcomes for people with diabetes-related foot complications. He is a Staff Specialist at St Vincent’s Hospital Sydney where he co-leads the High-Risk Foot Service (HRFS), accredited by the National Association of Diabetes Centres (NADC) as a Centre of Excellence.

Joel submitted his PhD via the Garvan Institute of Medical Research and University of New South Wales. He coordinates a novel randomised clinical trial for people with acute Charcot foot across nine hospitals. On invitation from Diabetes Feet Australia he co-authored the new Australian guideline on prevention of foot ulceration. He co-founded and convenes the Sydney Diabetic Foot Interest Group (SyD FIG), which brings together interdisciplinary clinicians from around the country.

As the NADC HRFS Database Manager, Joel is overseeing implementation of a standardised national database, with over forty services participating. He is also involved in NADC HRFS Accreditation.

SESSION DESCRIPTION

The Australian Diabetes Foot Registry (ADFR) is formed by a national collaboration of High-Risk Foot Services, with more than 40 sites now participating. The inaugural data pull was completed at end of June 2022 with analysis encompassing 19 sites, 1356 participants, 1447 care episodes and 2250 diabetes-related foot ulcerations.

The project provides an unprecedented opportunity to evaluate participant characteristics, referral processes, ulceration characteristics, clinical management and ultimately outcomes.

Early anonymous comparative data and potential benchmarking applications are presented, and future directions proposed.

PROF JONATHAN SHAW

Connecting the dots in data in diabetes databases - what do we need to do

Biography

Professor Jonathan Shaw MD FRCP(UK) FRACP FAAHMS

Professor Jonathan Shaw underwent his clinical and research training in the UK. He is Deputy Director (Clinical and Population Health) at Melbourne’s Baker Heart and Diabetes Institute, where his research focuses on epidemiology and clinical research in diabetes, and he is also a consultant physician in the diabetes services. He has authored over 500 peer-reviewed scientific papers and 35 book chapters.

He is the Chair of the Diabetes Advisory Group to the Australian Institute of Health and Welfare, Council member of the Australian Diabetes Society, and a Past-President of the International Diabetes Epidemiology Group. His awards include the global Novartis Diabetes Award (for research) (2006), the International Diabetes Epidemiology Group Peter Bennett award (2011), the Australian Diabetes Society’s Jeff Flack Diabetes Data award (2015), and the Australian Diabetes Society’s Kellion award (2108). In 2014, he was included in the Thomson Reuters The World’s Most Influential Scientific Minds, which listed the 1% most highly cited scientists in the world since 2002.

In 2017 and 2018, he was included in the Clarivate list of the world’s most Highly Cited Researchers. In 2020, he was listed in the Stanford University listing of the world’s top 2% of researchers.

SESSION DESCRIPTION

Large clinical and administrative databases offer many opportunities for understanding the burden of diabetes, but getting the full benefits of what is available can be challenging.

PROF TONY RUSSELL

Has COVID-19 changed the model of diabetes care?

Biography

Tony has been Director of the Department of Endocrinology and Diabetes at the Alfred, Melbourne since Jan 2022, after moving from the Princess Alexandra Hospital, Brisbane, where he was Director of Diabetes and Endocrinology for 16 years.

Tony is also Professor of Medicine with the School of Public Health and Preventive Medicine, Monash University.

Tony’s research interests are around models of care for management of diabetes; in particular integrated care with general practice and use of technology to support these models of care. He has 150 publications and has attracted over $12 million in research funding.

Tony is currently President of the Australian Diabetes Society.

SESSION DESCRIPTION

Has COVID-19 changed the model of diabetes care? The COVID-19 pandemic catapulted the uptake of virtual consultations for the management of diabetes. There has also been adoption of mHealth and virtual monitoring. Continued adoption of these technologies is likely to be maintained as long as funding models remain.

KAYE FARRELL

Models of Transition Care - are we delivering?

Biography

Dr. Kaye Farrell is a Clinical Nurse Consultant and since 2004 has been Co-ordinator of the multidisciplinary diabetes transition service for patients aged 15-25years at Westmead Hospital, Sydney. Her PhD thesis evaluated transition models of care, in particular the effectiveness of the Westmead Diabetes Transition Service model. The validated Care Transition Framework provided the theoretical underpinnings for the study.

Kaye has presented her research both nationally and internationally and has more than 15 publications, as first author or co-author, in international and national journals reporting on diabetes outcomes in young adults after transition from paediatric to adult health services. The service continues to provide research opportunities for medical and nursing disciplines.

Kaye is actively involved with adolescent and young adult services, transition committees and working groups within the LHD and is a member of the executive committee of the Agency of Clinical Innovation Transition Network at the state level.

SESSION DESCRIPTION

The session will explore the different models of transition care in context of

  • adolescent development
  • transition challenges
  • key principles of transition
  • current models of care outcomes
  • future models of care

DR RAHUL BARMANRAY

Diabetes Digital Phenotyping to Improve Documentation of Diabetes in Hospital Inpatients

Biography

Dr Rahul D Barmanray is an endocrinologist and general physician at The Royal Melbourne Hospital. He is currently completing his PhD in the field of inpatient diabetes with his early PhD work awarded the President’s Young Investigator’s Award at the 2020 Australasian Diabetes Congress.

He is particularly interested in the ability of technology to improve patient care, healthcare outcomes, and the patient experience. Rahul is also a committed educator and develops and delivers education to endocrinology advanced trainees through the Australian Diabetes Society and to medical students of the University of Melbourne.

Following his PhD work he plans to pursue his passions for diabetes, education, and technology as a clinician-researcher in these fields.

SESSION DESCRIPTION

While electronic medical records (EMRs) promise to streamline inpatient care and assist clinicians with medical decision support, an EMR is only as good as the data entered into it. When diabetes, among other diagnoses, is not entered as discrete data, EMR decision support cannot be provided to these patients. Digital phenotyping leverages other information in the medical record and an artificial intelligence technique known as natural language processing to detect diabetes diagnoses and apply these to appropriate patients.

This ensures all admitted patients with diabetes are known to the specialist inpatient diabetes team and the EMR, so can be optimally managed.

LUCY MARHAVA

Crossing the Road: Improving service delivery for young adults living with diabetes transitioning into adult healthcare.

Biography

Lucia Marhava is a Clinical Nurse Specialist and Credentialed Diabetes Educator. She works in both the Outpatient and Inpatient settings. Shie has experience with T1DM, T2DM, Diabetes in Young Adults, Diabetes in Older Adults and Metabolic clinics. She is passionate about supporting people living with diabetes with their daily challenges and to provide diabetes education and guidance.

SESSION DESCRIPTION

SVH Sydney Diabetes Centre has established a Diabetes in Youth (DIY) Clinic. This clinic commenced operating in June 2021. Establishment of this service was supported by Nursing and Midwifery Innovation Scholarship 2021. This presentation provides summary of how it all started and where are we up to now (17 months later).

CATHERINE FINNERAN

Development of Inpatient and Outpatient Metabolic Services and a Model of Care

Biography

Catherin is a Clinical Nurse Consultant and Credentialed Diabetes Educator. She has worked in both the Outpatient and Inpatient setting with experience in GDM, T1DM, T2DM, Metabolic Service and Young Adult Transition clinic. Her main focus since 2017 has been in the Inpatient Acute Hospital setting. This is a unique area for diabetes self-management education. She is passionate about patient advocacy and trying to ensure the patient remains empowered, involved and consulted in the Inpatient Diabetes therapy management. Her role also involves staff education to both medical and nursing, which is very rewarding.

She currently works fulltime as the Inpatient Diabetes Clinical Nurse Consultant at St Vincent’s Hospital in Sydney.

SESSION DESCRIPTION

Development of Inpatient and Outpatient Metabolic Services and a Model of Care. Patients with mental illness have a substantial increase in the prevalence of diabetes, obesity, and premature cardiovascular disease. Mental health and physical health care has traditionally worked separately. With the commencement of our service we have tried to bring these two areas closer together.